Search
Dermata Therapeutics Inc
DRMAAdd to Watchlist
1.185USD
+0.005+0.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.77MMarket Cap
LossP/E TTM
DRMA Balance Sheet
You can check out the annual or quarterly balance sheets of Dermata Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
Which balance sheet metrics matter most when analyzing DRMA stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Dermata Therapeutics Inc Have?
In its most recent quarterly, Dermata Therapeutics Inc had 6.95M in cash and cash equivalents.
How Much Shareholders' Equity Does Dermata Therapeutics Inc Have?
Dermata Therapeutics Inc reported 6.22M in total shareholders' equity as of the latest reported quarter.